Jang Soo Min, Jiang Ruixin, Grabe Darren, Pai Amy Barton
Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA, USA.
Department of Statistics, University of Michigan, Ann Arbor, MI, USA.
SAGE Open Med. 2019 Mar 7;7:2050312119834119. doi: 10.1177/2050312119834119. eCollection 2019.
Non-steroidal anti-inflammatory drugs are widely used and have a potential for over-the-counter misuse. Limited health literacy is associated with poor health outcomes. Identification of new strategies to assess literacy and numeracy could be useful in targeting effective education initiatives.
To characterize numeracy and literacy skills related to non-steroidal anti-inflammatory drug labels in primary care patients.
Patients were recruited and consented over an 8-month period after their regular primary care visit. Demographic information was collected and two instruments were administered to assess literacy and numeracy skills: (1) a medication label literacy instrument focused on non-steroidal anti-inflammatory drugs (MedLit-NSAID) and (2) a general healthy literacy-screening tool, the Newest Vital Sign. Two questions on the MedLit-NSAID instrument evaluated understanding of the Food and Drug Administration medication guide for non-steroidal anti-inflammatory drugs and the Food and Drug Administration approved over-the-counter label.
A total of 145 patients were enrolled. Mean MedLit-NSAID and Newest Vital Sign scores were 6.8 (scale range 0-8) and 4.2 (scale range 0-6), respectively. Higher education level was associated with higher scores for both tools (p ⩽ 0.05). Total MedLit-NSAID scores on average were higher in females compared with males (6.5 vs 6, p = 0.05). Patients with decreased kidney function (n = 18) had significantly lower MedLit-NSAID scores (p ⩽ 0.05). Test-retest scores were not significantly different for MedLit-NSAID (p = 0.32). The correlation between the tools was 0.54 and internal consistency MedLit-NSAID was 0.61.
A medication information focused instrument provided specific information to assess health literacy related to non-steroidal anti-inflammatory drug labels. This information could be utilized to develop patient education initiatives for medication label comprehension.
非甾体类抗炎药被广泛使用,存在非处方滥用的可能性。健康素养有限与不良健康结果相关。确定评估读写能力和计算能力的新策略可能有助于开展有效的教育举措。
描述初级保健患者中与非甾体类抗炎药标签相关的计算能力和读写能力。
在患者定期进行初级保健就诊后的8个月内招募并征得同意。收集人口统计学信息,并使用两种工具评估读写能力和计算能力:(1)一种专注于非甾体类抗炎药的药物标签读写能力工具(MedLit-NSAID),以及(2)一种一般健康素养筛查工具,即最新生命体征。MedLit-NSAID工具上的两个问题评估了对美国食品药品监督管理局非甾体类抗炎药用药指南和美国食品药品监督管理局批准的非处方标签的理解。
共纳入145名患者。MedLit-NSAID和最新生命体征的平均得分分别为6.8(评分范围0-8)和4.2(评分范围0-6)。较高的教育水平与两种工具的较高得分相关(p≤0.05)。女性的MedLit-NSAID总得分平均高于男性(6.5对6,p=0.05)。肾功能下降的患者(n=18)的MedLit-NSAID得分显著较低(p≤0.05)。MedLit-NSAID的重测得分无显著差异(p=0.32)。两种工具之间的相关性为0.54,MedLit-NSAID的内部一致性为0.61。
一种以药物信息为重点的工具提供了评估与非甾体类抗炎药标签相关的健康素养的具体信息。这些信息可用于制定患者教育举措,以促进对药物标签的理解。